...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial

Yes, the Cantos results were interesting but not surprising to me.

I've never been a firm believer in the LDL hypothesis. I always thought inflammation played a role.

Cantos results are consistent with that line of thinking.

However, I doubt this drug makes it to market for CAD.

Too expensive for so So results.

208 has a better chance...

 

bfw

Share
New Message
Please login to post a reply